Back to Search

Journal article

Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Wilcock, G., & Truyen, L. (2002). Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 12, S379–S380.

MLA Style

Wilcock, G., and L. Truyen. “Three-Year Follow-up of Galantamine Therapy for Alzheimer's Disease: Efficacy and Tolerability in Open-Label Extension Studies.” EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 12, 2002, pp. S379–S380.

Chicago Style

Wilcock, G, and L Truyen. 2002. “Three-Year Follow-up of Galantamine Therapy for Alzheimer's Disease: Efficacy and Tolerability in Open-Label Extension Studies.” EUROPEAN NEUROPSYCHOPHARMACOLOGY 12: S379–S380.
Tweet
Print

Authors

+ Wilcock, G More by this author

Role:

Author

+ Truyen, L More by this author

Role:

Author

Bibliographic Details

Journal:: EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume:: 12
Pages:: S379-S380
Publication date:: 2002-10-01
ISSN:: 0924-977X

Item Description

Pubs id:: pubs:60881
UUID:: uuid:04a62ed9-6c70-4ae5-8449-fd928bc7ffee
Local pid:: pubs:60881
Source identifiers:: 60881
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 2002

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP